Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 431 entries
Sorted by: Best Match Show Resources per page
Hydrophilic interaction chromatography combined with tandem mass spectrometry method for the quantification of tobramycin in human plasma and its application in a pharmacokinetic study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Chen L, Chen H, Shen M.
PMID: 25464093
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Dec 15;973:39-44. doi: 10.1016/j.jchromb.2014.10.007. Epub 2014 Oct 12.

A fast, sensitive and specific hydrophilic interaction chromatography combined with tandem mass spectrometry (HILIC-MS/MS) method was developed for the determination of tobramycin in human plasma. With sisomycin as internal standard, the analysis was carried out on a hilic column...

Cite
Chen L, Chen H, Shen M. Hydrophilic interaction chromatography combined with tandem mass spectrometry method for the quantification of tobramycin in human plasma and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;973:39-44doi: 10.1016/j.jchromb.2014.10.007.
Chen, L., Chen, H., & Shen, M. (2014). Hydrophilic interaction chromatography combined with tandem mass spectrometry method for the quantification of tobramycin in human plasma and its application in a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 97339-44. https://doi.org/10.1016/j.jchromb.2014.10.007
Chen, Lingyun, et al. "Hydrophilic interaction chromatography combined with tandem mass spectrometry method for the quantification of tobramycin in human plasma and its application in a pharmacokinetic study." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 973 (2014): 39-44. doi: https://doi.org/10.1016/j.jchromb.2014.10.007
Chen L, Chen H, Shen M. Hydrophilic interaction chromatography combined with tandem mass spectrometry method for the quantification of tobramycin in human plasma and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Dec 15;973:39-44. doi: 10.1016/j.jchromb.2014.10.007. Epub 2014 Oct 12. PMID: 25464093.
Copy Download .nbib Format: NLM
Post-traumatic endophthalmitis due to Brevibacterium casei : A case report.

The Australasian medical journal

Banu A, Ks S, M V, Er N.
PMID: 23483044
Australas Med J. 2013;6(2):70-2. doi: 10.4066/AMJ.2013.1523. Epub 2013 Feb 28.

Endophthalmitis is a serious post-traumatic ocular complication that can lead to loss of vision. We report a case of acute post-traumatic endophthalmitis following a penetrating injury caused by an unusual organism, Brevibacterium casei . The patient was successfully treated...

Cite
Banu A, Ks S, M V, et al. Post-traumatic endophthalmitis due to Brevibacterium casei : A case report. Australas Med J. 2013;6(2):70-2doi: 10.4066/AMJ.2013.1523.
Banu, A., Ks, S., M, V., & Er, N. (2013). Post-traumatic endophthalmitis due to Brevibacterium casei : A case report. The Australasian medical journal, 6(2), 70-2. https://doi.org/10.4066/AMJ.2013.1523
Banu, Asima, et al. "Post-traumatic endophthalmitis due to Brevibacterium casei : A case report." The Australasian medical journal vol. 6,2 (2013): 70-2. doi: https://doi.org/10.4066/AMJ.2013.1523
Banu A, Ks S, M V, Er N. Post-traumatic endophthalmitis due to Brevibacterium casei : A case report. Australas Med J. 2013;6(2):70-2. doi: 10.4066/AMJ.2013.1523. Epub 2013 Feb 28. PMID: 23483044; PMCID: PMC3593521.
Copy Download .nbib Format: NLM
Chronic suppurative otitis media: optimizing initial antibiotic therapy in a tertiary care setup.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Vishwanath S, Mukhopadhyay C, Prakash R, Pillai S, Pujary K, Pujary P.
PMID: 23998037
Indian J Otolaryngol Head Neck Surg. 2012 Sep;64(3):285-9. doi: 10.1007/s12070-011-0287-6. Epub 2011 Sep 13.

A prospective study was done to determine the clinico-microbiological profile and the antibiogram of patients with chronic suppurative otitis media. Ninety-four patients presenting with tympanic perforation and ear discharge of more than 3 months were studied. Middle ear swabs...

Cite
Vishwanath S, Mukhopadhyay C, Prakash R, et al. Chronic suppurative otitis media: optimizing initial antibiotic therapy in a tertiary care setup. Indian J Otolaryngol Head Neck Surg. 2011;64(3):285-9doi: 10.1007/s12070-011-0287-6.
Vishwanath, S., Mukhopadhyay, C., Prakash, R., Pillai, S., Pujary, K., & Pujary, P. (2012). Chronic suppurative otitis media: optimizing initial antibiotic therapy in a tertiary care setup. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 64(3), 285-9. https://doi.org/10.1007/s12070-011-0287-6
Vishwanath, Shashidhar, et al. "Chronic suppurative otitis media: optimizing initial antibiotic therapy in a tertiary care setup." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 64,3 (2012): 285-9. doi: https://doi.org/10.1007/s12070-011-0287-6
Vishwanath S, Mukhopadhyay C, Prakash R, Pillai S, Pujary K, Pujary P. Chronic suppurative otitis media: optimizing initial antibiotic therapy in a tertiary care setup. Indian J Otolaryngol Head Neck Surg. 2012 Sep;64(3):285-9. doi: 10.1007/s12070-011-0287-6. Epub 2011 Sep 13. PMID: 23998037; PMCID: PMC3431529.
Copy Download .nbib Format: NLM
Safety of Extended Interval Tobramycin in Cystic Fibrosis Patients Less an 6 Years Old.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Arends A, Pettit R.
PMID: 29720918
J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):152-158. doi: 10.5863/1551-6776-23.2.152.

OBJECTIVES: The primary objective of this study was to assess the nephrotoxicity and ototoxicity risks of extended interval tobramycin in cystic fibrosis (CF) patients who are

Cite
Arends A, Pettit R. Safety of Extended Interval Tobramycin in Cystic Fibrosis Patients Less an 6 Years Old. J Pediatr Pharmacol Ther. 2018;23(2):152-158doi: 10.5863/1551-6776-23.2.152.
Arends, A., & Pettit, R. (2018). Safety of Extended Interval Tobramycin in Cystic Fibrosis Patients Less an 6 Years Old. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 23(2), 152-158. https://doi.org/10.5863/1551-6776-23.2.152
Arends, Alexandria, and Pettit, Rebecca. "Safety of Extended Interval Tobramycin in Cystic Fibrosis Patients Less an 6 Years Old." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 23,2 (2018): 152-158. doi: https://doi.org/10.5863/1551-6776-23.2.152
Arends A, Pettit R. Safety of Extended Interval Tobramycin in Cystic Fibrosis Patients Less an 6 Years Old. J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):152-158. doi: 10.5863/1551-6776-23.2.152. PMID: 29720918; PMCID: PMC5916444.
Copy Download .nbib Format: NLM
Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro.

Journal of functional biomaterials

Harris M, Ahmed H, Pace L, Minter J, Neel M, Jennings J.
PMID: 30248929
J Funct Biomater. 2018 Sep 21;9(4). doi: 10.3390/jfb9040055.

Bone void fillers (BVFs) containing calcium sulfate, tricalcium phosphate (TCP), and hydroxyapatite can be loaded with antibiotics for infection treatment or prevention under surgeon-directed use. The aim of this study was to characterize the handling and elution properties of...

Cite
Harris M, Ahmed H, Pace L, et al. Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro. J Funct Biomater. 2018;9(4)doi: 10.3390/jfb9040055.
Harris, M., Ahmed, H., Pace, L., Minter, J., Neel, M., & Jennings, J. (2018). Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro. Journal of functional biomaterials, 9(4), . https://doi.org/10.3390/jfb9040055
Harris, Michael, et al. "Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro." Journal of functional biomaterials vol. 9,4 (2018). doi: https://doi.org/10.3390/jfb9040055
Harris M, Ahmed H, Pace L, Minter J, Neel M, Jennings J. Evaluation of Antibiotic-Releasing Triphasic Bone Void Filler In-Vitro. J Funct Biomater. 2018 Sep 21;9(4). doi: 10.3390/jfb9040055. PMID: 30248929; PMCID: PMC6306754.
Copy Download .nbib Format: NLM
Determination of Tobramycin in M.

Journal of analytical methods in chemistry

Huang L, Haagensen JAJ, Verotta D, Cheah V, Spormann AM, Aweeka F, Yang K.
PMID: 29854560
J Anal Methods Chem. 2018 Apr 26;2018:7965124. doi: 10.1155/2018/7965124. eCollection 2018.

It is well known that ion-pairing reagents cause ion suppression in LC-MS/MS methods. Here, we report that trichloroacetic acid increases the MS signal of tobramycin. To support studies of an

Cite
Huang L, Haagensen JAJ, Verotta D, et al. Determination of Tobramycin in M. J Anal Methods Chem. 2018;2018:7965124doi: 10.1155/2018/7965124.
Huang, L., Haagensen, J. A. J., Verotta, D., Cheah, V., Spormann, A. M., Aweeka, F., & Yang, K. (2018). Determination of Tobramycin in M. Journal of analytical methods in chemistry, 20187965124. https://doi.org/10.1155/2018/7965124
Huang, Liusheng, et al. "Determination of Tobramycin in M." Journal of analytical methods in chemistry vol. 2018 (2018): 7965124. doi: https://doi.org/10.1155/2018/7965124
Huang L, Haagensen JAJ, Verotta D, Cheah V, Spormann AM, Aweeka F, Yang K. Determination of Tobramycin in M. J Anal Methods Chem. 2018 Apr 26;2018:7965124. doi: 10.1155/2018/7965124. eCollection 2018. PMID: 29854560; PMCID: PMC5944200.
Copy Download .nbib Format: NLM
Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China.

Acta pharmaceutica Sinica. B

Nie L, Lv Y, Yuan M, Hu X, Nie T, Yang X, Li G, Pang J, Zhang J, Li C, Wang X, You X.
PMID: 26579398
Acta Pharm Sin B. 2014 Aug;4(4):295-300. doi: 10.1016/j.apsb.2014.06.004. Epub 2014 Jul 15.

The objective of this study was to investigate the genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii clinical isolates from Beijing, China. 173 A. baumannii clinical isolates from hospitals in Beijing from 2006 to 2009 were first...

Cite
Nie L, Lv Y, Yuan M, et al. Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta Pharm Sin B. 2014;4(4):295-300doi: 10.1016/j.apsb.2014.06.004.
Nie, L., Lv, Y., Yuan, M., Hu, X., Nie, T., Yang, X., Li, G., Pang, J., Zhang, J., Li, C., Wang, X., & You, X. (2014). Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta pharmaceutica Sinica. B, 4(4), 295-300. https://doi.org/10.1016/j.apsb.2014.06.004
Nie, Lu, et al. "Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China." Acta pharmaceutica Sinica. B vol. 4,4 (2014): 295-300. doi: https://doi.org/10.1016/j.apsb.2014.06.004
Nie L, Lv Y, Yuan M, Hu X, Nie T, Yang X, Li G, Pang J, Zhang J, Li C, Wang X, You X. Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta Pharm Sin B. 2014 Aug;4(4):295-300. doi: 10.1016/j.apsb.2014.06.004. Epub 2014 Jul 15. PMID: 26579398; PMCID: PMC4629078.
Copy Download .nbib Format: NLM
Comparison of the Safety and Efficacy of Loteprednol Etabonate 0.5%/Tobramycin 0.3% with Dexamethasone 0.1%/Tobramycin 0.3% Following Strabismus Surgery.

The Eurasian journal of medicine

Salman İA.
PMID: 28149143
Eurasian J Med. 2016 Oct;48(3):186-188. doi: 10.5152/eurasianjmed.2016.0264.

OBJECTIVE: To compare the anti-inflammatory efficacy and safety of 0.5% loteprednol etabonate/0.3% tobramycin (LE/T) and 0.1% dexamethasone/0.3% tobramycin (DM/T) ophthalmic suspensions following strabismus surgery.MATERIALS AND METHODS: The records of 40 patients who were treated with either LE/T or DM/T...

Cite
Salman İA. Comparison of the Safety and Efficacy of Loteprednol Etabonate 0.5%/Tobramycin 0.3% with Dexamethasone 0.1%/Tobramycin 0.3% Following Strabismus Surgery. Eurasian J Med. 2016;48(3):186-188doi: 10.5152/eurasianjmed.2016.0264.
Salman, �. �. A. (2016). Comparison of the Safety and Efficacy of Loteprednol Etabonate 0.5%/Tobramycin 0.3% with Dexamethasone 0.1%/Tobramycin 0.3% Following Strabismus Surgery. The Eurasian journal of medicine, 48(3), 186-188. https://doi.org/10.5152/eurasianjmed.2016.0264
Salman, İlknur Akyol. "Comparison of the Safety and Efficacy of Loteprednol Etabonate 0.5%/Tobramycin 0.3% with Dexamethasone 0.1%/Tobramycin 0.3% Following Strabismus Surgery." The Eurasian journal of medicine vol. 48,3 (2016): 186-188. doi: https://doi.org/10.5152/eurasianjmed.2016.0264
Salman İA. Comparison of the Safety and Efficacy of Loteprednol Etabonate 0.5%/Tobramycin 0.3% with Dexamethasone 0.1%/Tobramycin 0.3% Following Strabismus Surgery. Eurasian J Med. 2016 Oct;48(3):186-188. doi: 10.5152/eurasianjmed.2016.0264. PMID: 28149143; PMCID: PMC5268600.
Copy Download .nbib Format: NLM
Tobramycin and bicarbonate synergise to kill planktonic .

NPJ biofilms and microbiomes

Kaushik KS, Stolhandske J, Shindell O, Smyth HD, Gordon VD.
PMID: 28721244
NPJ Biofilms Microbiomes. 2016 May 25;2:16006. doi: 10.1038/npjbiofilms.2016.6. eCollection 2016.

Increasing antibiotic resistance and the declining rate at which new antibiotics come into use create a need to increase the efficacy of existing antibiotics. The aminoglycoside tobramycin is standard-of-care for many types of

Cite
Kaushik KS, Stolhandske J, Shindell O, et al. Tobramycin and bicarbonate synergise to kill planktonic . NPJ Biofilms Microbiomes. 2016;2:16006doi: 10.1038/npjbiofilms.2016.6.
Kaushik, K. S., Stolhandske, J., Shindell, O., Smyth, H. D., & Gordon, V. D. (2016). Tobramycin and bicarbonate synergise to kill planktonic . NPJ biofilms and microbiomes, 216006. https://doi.org/10.1038/npjbiofilms.2016.6
Kaushik, Karishma S, et al. "Tobramycin and bicarbonate synergise to kill planktonic ." NPJ biofilms and microbiomes vol. 2 (2016): 16006. doi: https://doi.org/10.1038/npjbiofilms.2016.6
Kaushik KS, Stolhandske J, Shindell O, Smyth HD, Gordon VD. Tobramycin and bicarbonate synergise to kill planktonic . NPJ Biofilms Microbiomes. 2016 May 25;2:16006. doi: 10.1038/npjbiofilms.2016.6. eCollection 2016. PMID: 28721244; PMCID: PMC5515257.
Copy Download .nbib Format: NLM
Combination antibiotics against .

Heliyon

Kapoor P, Murphy P.
PMID: 29560472
Heliyon. 2018 Mar 08;4(3):e00562. doi: 10.1016/j.heliyon.2018.e00562. eCollection 2018 Mar.

OBJECTIVES: To evaluate the effect of antibiotic combination therapy versus single therapy against cystic fibrosis strains of METHODS: This study compares the susceptibility profiles of RESULTS: There was no distinct virulence factors associated with clinical strains that were common...

Cite
Kapoor P, Murphy P. Combination antibiotics against . Heliyon. 2018;4(3):e00562doi: 10.1016/j.heliyon.2018.e00562.
Kapoor, P., & Murphy, P. (2018). Combination antibiotics against . Heliyon, 4(3), e00562. https://doi.org/10.1016/j.heliyon.2018.e00562
Kapoor, Priya, and Murphy, Philip. "Combination antibiotics against ." Heliyon vol. 4,3 (2018): e00562. doi: https://doi.org/10.1016/j.heliyon.2018.e00562
Kapoor P, Murphy P. Combination antibiotics against . Heliyon. 2018 Mar 08;4(3):e00562. doi: 10.1016/j.heliyon.2018.e00562. eCollection 2018 Mar. PMID: 29560472; PMCID: PMC5857811.
Copy Download .nbib Format: NLM
Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy.

La Tunisie medicale

Gargouri D, Ouakaa-Kchaou A, Kochlef A, Elloumi H, Bibani N, Trad D, Zili M, Kharrat J.
PMID: 26895121
Tunis Med. 2015 Oct;93(10):602-5.

BACKGROUND: Biliary obstruction together with bacterial colonization of the bile duct may lead to development of acute cholangitis. The reported incidence of infectious complications may reach up to 10%. Nevertheless, no antibiotic prophylaxis is administered routinely, prior to endoscopic...

Cite
Gargouri D, Ouakaa-Kchaou A, Kochlef A, et al. Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy. Tunis Med. 2015;93(10):602-5
Gargouri, D., Ouakaa-Kchaou, A., Kochlef, A., Elloumi, H., Bibani, N., Trad, D., Zili, M., & Kharrat, J. (2015). Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy. La Tunisie medicale, 93(10), 602-5.
Gargouri, Dalila, et al. "Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy." La Tunisie medicale vol. 93,10 (2015): 602-5.
Gargouri D, Ouakaa-Kchaou A, Kochlef A, Elloumi H, Bibani N, Trad D, Zili M, Kharrat J. Microbiological study and antimicrobial susceptibility of bile in biliary therapeutic endoscopy. Tunis Med. 2015 Oct;93(10):602-5. PMID: 26895121.
Copy Download .nbib Format: NLM
Class 1 integrons and plasmid-mediated multiple resistance genes of the .

Gut pathogens

Chang YC, Tien N, Yang JS, Lu CC, Tsai FJ, Huang TJ, Wang IK.
PMID: 28904565
Gut Pathog. 2017 Sep 09;9:50. doi: 10.1186/s13099-017-0199-4. eCollection 2017.

BACKGROUND: The RESULTS: The bacterial strains from the diarrhea of pediatric patient which isolated by China Medical University Hospital storage bank. These isolates were identified by MALDI-TOF mass spectrometry. The anti-microbial susceptibility test showed that Campylobacter species resistant to...

Cite
Chang YC, Tien N, Yang JS, et al. Class 1 integrons and plasmid-mediated multiple resistance genes of the . Gut Pathog. 2017;9:50doi: 10.1186/s13099-017-0199-4.
Chang, Y. C., Tien, N., Yang, J. S., Lu, C. C., Tsai, F. J., Huang, T. J., & Wang, I. K. (2017). Class 1 integrons and plasmid-mediated multiple resistance genes of the . Gut pathogens, 950. https://doi.org/10.1186/s13099-017-0199-4
Chang, Yi-Chih, et al. "Class 1 integrons and plasmid-mediated multiple resistance genes of the ." Gut pathogens vol. 9 (2017): 50. doi: https://doi.org/10.1186/s13099-017-0199-4
Chang YC, Tien N, Yang JS, Lu CC, Tsai FJ, Huang TJ, Wang IK. Class 1 integrons and plasmid-mediated multiple resistance genes of the . Gut Pathog. 2017 Sep 09;9:50. doi: 10.1186/s13099-017-0199-4. eCollection 2017. PMID: 28904565; PMCID: PMC5591528.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 431 entries